Literature DB >> 21224355

Minimal engagement of CD103 on cytotoxic T lymphocytes with an E-cadherin-Fc molecule triggers lytic granule polarization via a phospholipase Cgamma-dependent pathway.

Audrey Le Floc'h1, Abdelali Jalil, Katarzyna Franciszkiewicz, Pierre Validire, Isabelle Vergnon, Fathia Mami-Chouaib.   

Abstract

Interaction of the integrin αE(CD103)β7 expressed on tumor-infiltrating lymphocytes (TIL) with E-cadherin on epithelial tumor cells is required to trigger polarized exocytosis of cytotoxic granules in TIL that elicit tumor cell lysis. In this study, we investigated the functional and signaling properties of CD103 and its individual contribution to T-cell-mediated cancer-cell killing. Our results indicated that the binding of CD103 on tumor-specific CTL to immobilized recombinant E-cadherin-Fc is sufficient to induce the polarization of cytolytic granules, whereas the degranulation of cytolytic granules also requires the coengagement of the T-cell receptor. Moreover, minimal CD103 triggering promotes the phosphorylation of the ERK1/2 kinases and phospholipase Cγ1 (PLCγ1). Inhibiting PLCγ blocks granule relocalization, decreasing T-cell receptor-mediated cytotoxicity. Thus, our results emphasize a unique costimulatory role of CD103 in tumor-specific CTL activation by providing signals that promote T-cell effector functions needed to specifically target and lyse cancer cells.
© 2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21224355     DOI: 10.1158/0008-5472.CAN-10-2457

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

Review 1.  Tissue-Resident Cytolytic Innate Lymphocytes in Cancer.

Authors:  Briana G Nixon; Ming O Li
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

2.  Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund's adjuvant, with or without peptide.

Authors:  Elise P Salerno; Sofia M Shea; Walter C Olson; Gina R Petroni; Mark E Smolkin; Chantel McSkimming; Kimberly A Chianese-Bullock; Craig L Slingluff
Journal:  Cancer Immunol Immunother       Date:  2013-05-09       Impact factor: 6.968

3.  Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma.

Authors:  Bradley D Shields; Brian Koss; Erin M Taylor; Aaron J Storey; Kirk L West; Stephanie D Byrum; Samuel G Mackintosh; Rick Edmondson; Fade Mahmoud; Sara C Shalin; Alan J Tackett
Journal:  Cancer Res       Date:  2019-01-23       Impact factor: 12.701

4.  Prognostic and therapeutic value of CD103+ cells in renal cell carcinoma.

Authors:  Jin Zhou; Lipeng Liu; Tuo Yang; Bingxin Lu
Journal:  Exp Ther Med       Date:  2018-04-02       Impact factor: 2.447

5.  Reprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection.

Authors:  Te-Chia Wu; Kangling Xu; Romain Banchereau; Florentina Marches; Chun I Yu; Jan Martinek; Esperanza Anguiano; Alexander Pedroza-Gonzalez; G Jackson Snipes; Joyce O'Shaughnessy; Stephen Nishimura; Yong-Jun Liu; Virginia Pascual; Jacques Banchereau; Sangkon Oh; Karolina Palucka
Journal:  Cancer Immunol Res       Date:  2014-03-04       Impact factor: 11.151

6.  Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy.

Authors:  Jeffrey C Thompson; Wei-Ting Hwang; Christiana Davis; Charuhas Deshpande; Seth Jeffries; Yashoda Rajpurohit; Vinod Krishna; Denis Smirnov; Raluca Verona; Matthew V Lorenzi; Corey J Langer; Steven M Albelda
Journal:  Lung Cancer       Date:  2019-10-18       Impact factor: 5.705

7.  Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells.

Authors:  Ilkka Liikanen; Colette Lauhan; Sara Quon; Kyla Omilusik; Anthony T Phan; Laura Barceló Bartrolí; Amir Ferry; John Goulding; Joyce Chen; James P Scott-Browne; Jason T Yustein; Nicole E Scharping; Deborah A Witherden; Ananda W Goldrath
Journal:  J Clin Invest       Date:  2021-04-01       Impact factor: 14.808

8.  γδ Intraepithelial Lymphocytes Facilitate Pathological Epithelial Cell Shedding Via CD103-Mediated Granzyme Release.

Authors:  Madeleine D Hu; Natasha B Golovchenko; Grace L Burns; Prema M Nair; Thomas J Kelly; Jonathan Agos; Mudar Zand Irani; Wai Sinn Soh; Matthew R Zeglinski; Alexander Lemenze; Edward M Bonder; Inga Sandrock; Immo Prinz; David J Granville; Simon Keely; Alastair J M Watson; Karen L Edelblum
Journal:  Gastroenterology       Date:  2021-12-01       Impact factor: 22.682

Review 9.  Re(de)fining Innate Lymphocyte Lineages in the Face of Cancer.

Authors:  Chun Chou; Ming O Li
Journal:  Cancer Immunol Res       Date:  2018-04       Impact factor: 11.151

10.  Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses.

Authors:  Yanchun Peng; Tao Dong; Megat Abd Hamid; Huw Colin-York; Nasullah Khalid-Alham; Molly Browne; Lucia Cerundolo; Ji-Li Chen; Xuan Yao; Samara Rosendo-Machado; Craig Waugh; David Maldonado-Perez; Emma Bowes; Clare Verrill; Vincenzo Cerundolo; Christopher P Conlon; Marco Fritzsche
Journal:  Cancer Immunol Res       Date:  2019-11-26       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.